Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:17
Schlesinger’s Saturday Showcase (1/18)---Waukesha JanBoree,...
-
2:43
Coldest air of the season parking itself here to start a new...
-
1:46
UWM’s Stillwell’s ’motor’ propels him to top of nation’s...
-
2:31
Racine Zoo announces passing of Masai giraffe Jabari
-
1:52
Bob Uecker leaves lasting impact on local restaurant
-
2:25
Brewers place banner inside ballpark for fans to leave Uecker...
-
2:34
TikTok says it will go dark Sunday unless Biden administration...
-
2:04
Racine teen sentenced to 20 years in prison for attempting to...
-
2:26
Make-A-Wish recipient remembers Bob Uecker
-
1:57
Marquette police officer facing charges after investigators say...
-
1:21
400 boats fill the Wisconsin State Fair Expo Center for the next...
-
1:02
Hometown window washer recalls Uecker signing baseball bat
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.